Titel

Merkliste
1 Ergebnisse

The type II RAF inhibitor tovorafenib in relapsed/refractor..:

Kilburn, LB ; Khuong-Quang, DA ; Hansford, JR...
https://discovery.ucl.ac.uk/id/eprint/10182485/1/Hargrave_The%20type%20II%20RAF%20inhibitor%20tovorafenib%20in%20relapsed_VoR.pdf. , 2023

Link: https://discovery.ucl.ac.uk/id/eprint/10182485/1/Hargr..

RT Journal
T1 <Title>The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftucl:oai:eprints.ucl.ac.uk.OAI2:10182485&Exemplar=1&LAN=DE
				
A1 Kilburn, LB
A1 Khuong-Quang, DA
A1 Hansford, JR
A1 Landi, D
A1 van der Lugt, J
A1 Leary, SES
A1 Driever, PH
A1 Bailey, S
A1 Perreault, S
A1 McCowage, G
A1 Waanders, AJ
A1 Ziegler, DS
A1 Witt, O
A1 Baxter, PA
A1 Kang, HJ
A1 Hassall, TE
A1 Han, JW
A1 Hargrave, D
A1 Franson, AT
A1 Yalon Oren, M
A1 Toledano, H
A1 Larouche, V
A1 Kline, C
A1 Abdelbaki, MS
A1 Jabado, N
A1 Gottardo, NG
A1 Gerber, NU
A1 Whipple, NS
A1 Segal, D
A1 Chi, SN
A1 Oren, L
A1 Tan, EEK
A1 Mueller, S
A1 Cornelio, I
A1 McLeod, L
A1 Zhao, X
A1 Walter, A
A1 Da Costa, D
A1 Manley, P
A1 Blackman, SC
A1 Packer, RJ
A1 Nysom, K
PB Springer Science and Business Media LLC
YR 2023
K1 Drug development
K1 Paediatric cancer
K1 Phase II trials; Randomized controlled trials; Targeted therapies
JF https://discovery.ucl.ac.uk/id/eprint/10182485/1/Hargrave_The%20type%20II%20RAF%20inhibitor%20tovorafenib%20in%20relapsed_VoR.pdf
LK http://dx.doi.org/https://discovery.ucl.ac.uk/id/eprint/10182485/1/Hargrave_The%20type%20II%20RAF%20inhibitor%20tovorafenib%20in%20relapsed_VoR.pdf
DO https://discovery.ucl.ac.uk/id/eprint/10182485/1/Hargrave_The%20type%20II%20RAF%20inhibitor%20tovorafenib%20in%20relapsed_VoR.pdf
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)